Cargando…

Improvement in the ability to have sex in patients with Peyronie's disease treated with Collagenase Clostridium histolyticum

OBJECTIVE: To describe the results of intralesional Collagenase Clostridium histolyticum (CCH) treatment in patients with Peyronie's disease (PD) in real‐world setting. PD is characterized by curvature of the erect penis caused by fibrotic tissue in the tunica albuginea. PATIENTS AND METHODS: P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geelhoed, Jeannette P., Wegelin, Olivier, Tromp, Ellen, de Boer, Bert‐Jan, de Jong, Igle‐Jan, Beck, Jack J. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766863/ https://www.ncbi.nlm.nih.gov/pubmed/36569498 http://dx.doi.org/10.1002/bco2.185

Ejemplares similares

Role of collagenase clostridium histolyticum in Peyronie’s disease
por: Peak, Taylor C, et al.
Publicado: (2015)

Collagenase Clostridium histolyticum in the treatment of Peyronie’s disease: patient selection and perspectives
por: Kuhlmann, Paige K, et al.
Publicado: (2017)

Racial variations in response to intralesional collagenase clostridium histolyticum in men with Peyronie’s disease
por: Nguyen, Hoang Minh Tue, et al.
Publicado: (2017)

AB041. Experience in the use of collagenase clostridium histolyticum in the management of Peyronie’s disease
por: Jad, Amr, et al.
Publicado: (2016)

The Impact of Clostridium Histolyticum Collagenase on the Prevalence and Management of Peyronie's Disease in the United States
por: Sun, Andrew J., et al.
Publicado: (2019)

Peyronie’s disease – outcomes of collagenase clostridium histolyticum injection: A systematic review
por: Mefford, Austin T., et al.
Publicado: (2021)

Lateral herniation during treatment with collagenase Clostridium histolyticum (Xiaflex) for Peyronie’s disease
por: Gannon, Margaret K., et al.
Publicado: (2021)

Effect of collagenase Clostridium histolyticum on penile vascular and morphological parameters in patients with Peyronie’s disease
por: Diao, Linley, et al.
Publicado: (2017)

Collagenase clostridium histolyticum intralesional injections for the treatment of Peyronie’s disease: a safety profile
por: Yan, Sylvia, et al.
Publicado: (2017)

Complications and other concerns with intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease
por: Levine, Laurence A.
Publicado: (2017)

Expanding the role of injectable collagenase clostridium histolyticum for the treatment of active phase Peyronie’s disease
por: Aliperti, Louis A., et al.
Publicado: (2017)

Efficacy and Safety of Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: An Evidence-Based Analysis
por: Cao, Dehong, et al.
Publicado: (2022)

Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: Review of a Minimally Invasive Treatment Option
por: Gabrielson, Andrew T, et al.
Publicado: (2017)

Safety and Efficacy Study of Collagenase Clostridium Histolyticum Applied With an Intensive Protocol in the Treatment of Peyronie's Disease
por: Melgarejo-Segura, Mª Teresa, et al.
Publicado: (2021)

Surgical outcomes after collagenase Clostridium histolyticum failure in patients with Peyronie’s disease in a multicenter clinical study
por: Cocci, Andrea, et al.
Publicado: (2021)

Changes in the Effects of Peyronie's Disease After Treatment With Collagenase Clostridium histolyticum: Male Patients and Their Female Partners
por: Goldstein, Irwin, et al.
Publicado: (2017)

Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease
por: Kadioglu, Ates, et al.
Publicado: (2017)

Intralesional collagenase Clostridium histolyticum for acute phase Peyronie’s disease: a single-center, retrospective cohort study
por: Hu, Ming-Yeah Y., et al.
Publicado: (2022)

Re: Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease
por: Kahn, Barbara, et al.
Publicado: (2017)

Patient perspectives on Peyronie’s disease: results of poststudy interviews from a phase 2 trial of collagenase clostridium histolyticum
por: Kaminetsky, J., et al.
Publicado: (2018)

Editorial Comment: Impact of the advent of collagenase clostridium histolyticum on the surgical management of Peyronie's disease: a population-based analysis
por: Sukumar, S, et al.
Publicado: (2020)

How Atypical Penile Curvature Influence Clinical Outcomes in Patients with Peyronie's Disease Receiving Collagenase Clostridium Histolyticum Therapy?
por: Cocci, Andrea, et al.
Publicado: (2020)

The efficacy and safety of intralesional injection of collagenase Clostridium histolyticum for Peyronie’s disease: A meta-analysis of published prospective studies
por: Zhang, Fuxun, et al.
Publicado: (2022)

Penile surgery for patients with Peyronie’s disease initially treated with collagenase clostridium histolyticum or surgery: a claims database analysis
por: Trost, Landon, et al.
Publicado: (2022)

Monitoring the Degradation of Collagen Hydrogels by Collagenase Clostridium histolyticum
por: Ng, Hon Wei, et al.
Publicado: (2020)

Treatment Patterns and Healthcare Outcomes with Collagenase Clostridium Histolyticum vs Surgery in Peyronie's Disease: A Retrospective Claims Database Analysis
por: Trost, Landon, et al.
Publicado: (2021)

Treatment of Peyronie’s disease via preoperative intralesional collagenase clostridium histolyticum followed by placement of an inflatable penile prosthesis: the new standard of care?
por: Akerman, Jason, et al.
Publicado: (2017)

The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease
por: Thomas, Alexis, et al.
Publicado: (2010)

Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren’s contracture
por: Peimer, C. A., et al.
Publicado: (2015)

Collagenase Clostridium histolyticum : emerging practice patterns and treatment advances
por: Warwick, David, et al.
Publicado: (2016)

New Considerations in the Use of Collagenase Clostridium Histolyticum for the Treatment of Cellulite
por: Grekin, Jeremy A, et al.
Publicado: (2023)

Intralesional collagenase clostridium histolyticum study provides real-world analysis
por: Haney, Nora M., et al.
Publicado: (2016)

Collagenase clostridium hystolyticum in the management of Peyronie’s disease
por: Ahn, Sun Tae, et al.
Publicado: (2017)

Late Complications of Clinical Clostridium Histolyticum Collagenase Use in Dupuytren's Disease
por: Rozen, Warren M., et al.
Publicado: (2012)

Editorial Comment: Comparative Cost-effectiveness of Surgery, Collagenase Clostridium Histolyticum, and Penile Traction Therapy in Men with Peyronie's Disease in an Era of Effective Clinical Treatment
por: Wymer, K, et al.
Publicado: (2020)

Return-to-Function Following Treatment of Dupuytren Contracture With Collagenase Clostridium Histolyticum Versus Fasciectomy
por: Divino, Victoria M., et al.
Publicado: (2020)

Multiple concurrent collagenase clostridium histolyticum injections to dupuytren’s cords: an exploratory study
por: Coleman, Stephen, et al.
Publicado: (2012)

Retraction: Late Complications of Clinical Clostridium Histolyticum Collagenase Use in Dupuytren's Disease
por: Rozen, Warren M., et al.
Publicado: (2012)

Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up
por: Nayar, Suresh K., et al.
Publicado: (2019)

Efficacy, Safety, and Durability of Response of Collagenase Clostridium Histolyticum-aaes for Treating Cellulite
por: Kaufman-Janette, Joely A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0sgup3sjht85s763rlb3t2vd78